Skip to main content
Fig. 1 | Hereditas

Fig. 1

From: Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approach

Fig. 1

COVID-19 caused a series of biological course changes in cancer patients, which have rendered the original treatment ineffective. GINS1 was reported to promote antigen recognition and involve cancer development. GINS1 has been considered to be a promising target for the treatment of cancer patients infected with COVID-19. The eight compounds have been found to target GINS1 as potential small molecule inhibitors for the clinical treatments of cancer patients infected with COVID-19

Back to article page

Hereditas

ISSN: 1601-5223

Contact us